tadalafil has been researched along with quercetin in 2 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 12,403 | 239 | 7,510 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cichero, E; D'Ursi, P; Fossa, P; Moscatelli, M; Orro, A; Padoan, R; Pedemonte, N; Pesce, E; Rusnati, M; Uggeri, M; Urbinati, C | 1 |
2 other study(ies) available for tadalafil and quercetin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library.
Topics: Cystic Fibrosis Transmembrane Conductance Regulator; Datasets as Topic; Dose-Response Relationship, Drug; Drug Repositioning; Humans; Molecular Structure; Phenylalanine; Small Molecule Libraries; Structure-Activity Relationship | 2021 |